We are excited to announce that MAPP’s new study, called the Symptom Pattern Study, is open for recruitment.
The Symptom Pattern Study (MAPP 2) takes what we learned from the Epidemiology and Phenotyping Study (MAPP 1) and sets out to answer new research questions. The ultimate goal of MAPP is discover the underlying cause(s) of urologic chronic pelvic pain. The hope is that discoveries from this study will lead toward better, more personalized treatment options for these conditions. To reach these goals MAPP 2 will:
- Track participants over a longer period of time than previous studies, so we can improve our understanding of what causes symptoms to get better or worse.
- Take images of the brain using magnetic resonance imaging (MRI) to see how brain activity and structure relate to pelvic pain.
- Investigate the functioning of the central nervous system (which sends signals throughout the body) in people with chronic pelvic pain.
- Conduct genetic testing to better understand how differences in DNA affect pelvic symptoms.
- Collect biological specimens to look for markers or microbes that correlate with bladder or prostate pain.
- Follow any changes in medical treatment for pelvic pain to see how effective different therapies are.
To get started, visit our Study Participation page.